Evidence map›Paper›PMID 20678570›Full record

ArticleFree radical biology & medicine2010

Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins.

Kalavathi Dasuri, Philip J Ebenezer, Le Zhang, Sun Ok Fernandez-Kim, Romina M Uranga, Elena Gavilán, Alessia Di Blasio, Jeffrey N Keller

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. A Practical Review of Proteasome Pharmacology.Pharmacological reviews · 2019
    Review
  4. Article
  5. The Proteasome Inhibition Model of Parkinson's Disease.Journal of Parkinson's disease · 2017
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kalavathi DasuriPennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808-4124, USA.
Philip J Ebenezer
Le Zhang
Sun Ok Fernandez-Kim
Romina M Uranga
Elena Gavilán
Alessia Di Blasio
Jeffrey N Keller
Pennington Biomedical Research Center · USLouisiana State University System · USUniversidad Nacional del Sur · AR

Funding

Dietary restriction and proteasome-mediated protein degradation in the aging CNSR01AG029885 · NIA · UNIVERSITY OF KENTUCKY · PI KELLER, JEFFREY NEIL · 2007 to 2011
$1.4M
Dietary restriction, aging, and the proteasomeR01AG025771 · NIA · UNIVERSITY OF KENTUCKY · PI KELLER, JEFFREY NEIL · 2007 to 2011
$1.3M
NIA NIH HHS AG025771NIA NIH HHS AG029885NIA NIH HHS R01 AG025771NIA NIH HHS R01 AG029885
6 · The paper itself

Abstract

Maintaining protein homeostasis is vital to cell viability, with numerous studies demonstrating a role for proteasome inhibition occurring during the aging of a variety of tissues and, presumably, contributing to the disruption of cellular homeostasis during aging. In this study we sought to elucidate the differences between neurons and astrocytes in regard to basal levels of protein synthesis, proteasome-mediated protein degradation, and sensitivity to cytotoxicity after proteasome inhibitor treatment. In these studies we demonstrate that neurons have an increased vulnerability, compared to astrocyte cultures, to proteasome-inhibitor-induced cytotoxicity. No significant difference was observed between these two cell types in regard to the basal rates of protein synthesis, or basal rates of protein degradation, in the pool of short-lived proteins. After proteasome inhibitor treatment neuronal crude lysates were observed to undergo greater increases in the levels of ubiquitinated and oxidized proteins and selectively exhibited increased levels of newly synthesized proteins accumulating within the insoluble protein pool, compared to astrocytes. Together, these data suggest a role for increased oxidized proteins and sequestration of newly synthesized proteins in the insoluble protein pool, as potential mediators of the selective neurotoxicity after proteasome inhibitor treatment. The implications for neurons exhibiting increased sensitivity to acute proteasome inhibitor exposure, and the corresponding changes in protein homeostasis observed after proteasome inhibition, are discussed in the context of both aging and age-related disorders of the nervous system.

Indexed as

Oxidative StressAgingAnimalsAstrocytesCell ExtractsCells, CulturedCysteine Proteinase InhibitorsHumansLeupeptinsNeuronsNeurotoxicity SyndromesOxidation-ReductionProteasome InhibitorsRatsRats, Sprague-DawleySolubilitybenzyloxycarbonylleucyl-leucyl-leucine aldehydeCell ExtractsCysteine Proteinase InhibitorsLeupeptinsProteasome Inhibitors

Identifiers

PMID20678570
PMCPMC3175605
OpenAlexW2067730748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.